<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00224718</url>
  </required_header>
  <id_info>
    <org_study_id>P000708</org_study_id>
    <secondary_id>AOM 98167</secondary_id>
    <nct_id>NCT00224718</nct_id>
  </id_info>
  <brief_title>Elective Abdominal Aortic Aneurism - Open Versus Endovascular Repair</brief_title>
  <acronym>ACE</acronym>
  <official_title>ACE Trial :Not Worn-Out Aneurism of the Abdominal Aorta Under Renal &quot; Surgery Versus Endoprosthesis &quot;</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assistance Publique - Hôpitaux de Paris</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assistance Publique - Hôpitaux de Paris</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Abdominal aortic aneurysm (AAA) is a life threatening disease. There is a consensus to
      propose surgical repair in patients with a reasonable operative risk when the AAA exceeds 5
      cm in diameter.

      The aim of the study is to compare the mortality and the occurrence of severe general,
      vascular and local complications in two groups of patients treated by either by open surgery
      or by EVAR (EndoVascular Aneurysm Repair). The main outcome criteria and the secondary
      endpoint are respectively the survival without severe complications and minor morbidity.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      ACE Trial :Not Worn-Out Aneurism of the Abdominal Aorta Under Renal &quot; Surgery Versus
      Endoprosthesis Abdominal aortic aneurysm (AAA) is a life threatening disease. There is a
      consensus to propose surgical repair in patients with a reasonable operative risk when the
      AAA exceeds 5 cm in diameter.

      The aim of the study is to compare the mortality and the occurrence of severe general,
      vascular and local complications in two groups of patients treated by either by open surgery
      or by EVAR (EndoVascular Aneurysm Repair). The main outcome criteria and the secondary
      endpoint are respectively the survival without severe complications and minor morbidity.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>January 2003</start_date>
  <completion_date type="Actual">February 2009</completion_date>
  <primary_completion_date type="Actual">February 2008</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Death and major adverse events</measure>
    <time_frame>4 years</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Minor adverse events (systemic vascular or non vascular complications)</measure>
    <time_frame>4 years</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">306</enrollment>
  <condition>Elective Abdominal Aortic Aneurysm</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>surgery - open repair</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>endovascular procedure</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Endovascular repair (with endograft)</intervention_name>
    <description>An endovascular stent graft is a tube composed of fabric supported by a metal mesh called a stent. It can be used for a variety of conditions involving the blood vessels, but most commonly to reinforce a weak spot in an artery called an aneurysm. Over time, blood pressure and other factors can cause this weak area to bulge like a balloon and eventually enlarge and rupture. The stent graft seals tightly with your artery above and below the aneurysm. The graft is stronger than the weakened artery and allows blood to pass through it without pushing on the bulge. Physicians typically use endovascular stent grafting to treat abdominal aortic aneurysms (AAAs).</description>
    <arm_group_label>2</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Open repair</intervention_name>
    <description>Conventional repair consist in open repair. Different types of surgery can be done : minimal incision aortic surgery (MIAS), transperitoneal approach (TPA), retroperitoneal repair, or conventional median laparotomy.</description>
    <arm_group_label>1</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients aged 50 years old or more (more than 80 possible depending on physiological
             age)

          -  Level 0, 1, or 2 of operative risk

          -  Abdominal aortic aneurysm with a diameter &gt; or equal to 50 mm or &gt; or equal to 40 mm
             if rapid growing (10 mm or more in a year), or painful, or saccular aneurysms, or
             aneurisms of common iliac arteries with a diameter equal or superior to 30 mm; or
             women with a diameter equal to 45 mm;

          -  Aortic neck superior or equal to 1.5 cm

          -  No stenosis superior or equal to 75% of the superior mesenteric artery

          -  Proximal neck angulation inferior to 80°

          -  Diameter of the iliac arteries compatible with introducer sheath

          -  Inform consent signed

        Exclusion Criteria:

          -  Aneurysm involving the renal arteries or with the length of the neck less than 1.5 cm

          -  Thrombus or major calcification in the neck

          -  Diameter of the iliac arteries not compatible with introducer sheath

          -  Level 3 of operative risk

          -  History of major iodine allergy (Quincke oedema, anaphylactic shock)

          -  Other comorbidity with life expectancy less than 6 months

          -  Follow up impossible during the trial

          -  Participation in another trial

          -  Inform consent not signed
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>50 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Yann JOUSSET, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>CHU Angers - Hôtel Dieu</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Jean M Pernes, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hôpital privé d'Antony</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Pierre Y Meaulle, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Clinique mutualiste des Eaux Claires, Grenoble</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Jean P Favre, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>CHU Hôpital Nord, Saint-Etienne</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Jacques Watelet, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hôpital Charles Nicolle, Rouen</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Patrick Lermusiaux, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>CHRU -Hôpital Trousseau, Tours</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Jean F Heautot, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>CHU de Pontchaillou, Rennes</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Mohamad KOUSSA, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hôpital Cardiologique , Lille</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Patrice BERGERON, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hôpital St Joseph, Marseille</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Philippe CHAILLOU, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hôpital Nord Laennec, Nantes</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Eric CHEYSSON, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Centre Hospitalier René Dubos, Pontoise</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Arnaud DEMON, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>CH de Valenciennes</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Jean C PILLET, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Nouvelles Cliniques Nantaises, Nantes</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Eric STEINMETZ, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>CHU de Dijon - Hôpital du Bocage</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Michel LEVADE, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Clinique Pasteur, Toulouse</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Jean CARDON, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Clinique des Franciscaines, Nimes</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Pierre-Edouard MAGNAN, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>CHU Timone, Marseille</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Michel Batt, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hôpital St-Roch, Nice</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Pierre GOUNY, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hopital de la cavale blanche, Brest</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Antoine Lucas, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>CHU Pontchaillou</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Jean P Becquemin, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Hopital Henri Mondor, Créteil</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Marc Sapoval, MD</last_name>
    <role>Study Chair</role>
    <affiliation>HEGP, Paris</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Hopital Henri Mondor</name>
      <address>
        <city>Creteil</city>
        <zip>94 010</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <link>
    <url>http://www.cacvs.org</url>
    <description>controversies and updates in vascular surgery</description>
  </link>
  <reference>
    <citation>Lederle FA. Endovascular repair of abdominal aortic aneurysm--round two. N Engl J Med. 2005 Jun 9;352(23):2443-5.</citation>
    <PMID>15944430</PMID>
  </reference>
  <verification_date>February 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 16, 2005</study_first_submitted>
  <study_first_submitted_qc>September 19, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 23, 2005</study_first_posted>
  <last_update_submitted>March 31, 2009</last_update_submitted>
  <last_update_submitted_qc>March 31, 2009</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 1, 2009</last_update_posted>
  <responsible_party>
    <name_title>Cecile Jourdain / Project manager</name_title>
    <organization>Departement Clinical Research of Developpement</organization>
  </responsible_party>
  <keyword>Abdominal aortic aneurysm</keyword>
  <keyword>Endograft</keyword>
  <keyword>Open repair</keyword>
  <keyword>Endovascular repair</keyword>
  <keyword>AAA</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Aneurysm</mesh_term>
    <mesh_term>Aortic Aneurysm</mesh_term>
    <mesh_term>Aortic Aneurysm, Abdominal</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

